Senators Press FTC to Finalize Pharmacy Benefit Manager Study
Sens. Chuck Grassley and Maria Cantwell are urging the Federal Trade Commission to complete and publicly release its Section 6(b) study of pharmacy benefit manager practices, opened in June 2022, with recommendations for Congress. The oversight push creates no immediate procurement action, but the eventual findings could influence prescription-drug market rules and contracting assumptions.